Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy in head and neck squamous cell carcinoma: An updated review
Kanak Parmar, Abdallah Mohamed, E. Vaish, et al.
Cancer Treatment and Research Communications (2022) Vol. 33, pp. 100649-100649
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 22
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 7
Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
Lei‐Ming Cao, Nian‐Nian Zhong, Yang Chen, et al.
Cancer Letters (2024) Vol. 598, pp. 217095-217095
Closed Access | Times Cited: 6
Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
K. Devaraja, Sadhna Aggarwal, Manisha Singh
Vaccines (2023) Vol. 11, Iss. 3, pp. 634-634
Open Access | Times Cited: 14
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
Nathan Wamsley, Emily Wilkerson, Li Guan, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 11, pp. 100647-100647
Open Access | Times Cited: 14
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma
Camilla Palumbo, Monica Benvenuto, Chiara Focaccetti, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
A Review of Immunotherapy for Head and Neck Cancer
Joëlle Goetz, Guilherme Rabinowits, Noah S. Kalman, et al.
Journal of Dental Research (2024) Vol. 103, Iss. 12, pp. 1185-1196
Closed Access | Times Cited: 4
Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors
Jie Wang, Rong Wang, Meifeng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma
Ameet A. Chimote, Maria Lehn, Jay Bhati, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1008-1008
Open Access | Times Cited: 3
Knockdown of Ubiquitin-Conjugating Enzyme E2 T Abolishes the Progression of Head and Neck Squamous Cell Carcinoma by Inhibiting NF-Κb Signaling and inducing Ferroptosis
Feng Cai, Hongbo Xu, Shilong Song, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 577-585
Closed Access | Times Cited: 3
Effects of Vitamin D on tumor cell proliferation and migration, tumor initiation and anti-tumor immune response in head and neck squamous cell carcinomas
Lukas Brust, Maximilian Linxweiler, Jana Schnatmann, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117497-117497
Open Access | Times Cited: 3
Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients
Andrea Sacconi, Paola Muti, Claudio Pulito, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Global trend and risk factors of the disease burden for pharynx and larynx cancers between 1990 and 2019: a systematic analysis of the global burden of disease study 2019
Ao Huang, Xing-liang Wu, Jia Song, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Head and neck cancer treatment in the era of molecular medicine
Subramanya Pandruvada, Remi Kessler, Ann Thai
Advances in cancer research (2023), pp. 205-252
Closed Access | Times Cited: 7
The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review)
Yu Feng, Xiulei Li, Bingwu Yang, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 2
Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma (Review)
Doriana Iancu, Ana Fulga, Doina Vesa, et al.
Molecular and Clinical Oncology (2024) Vol. 20, Iss. 6
Open Access | Times Cited: 2
Predictive value of early dynamic changes of NLR and PLR for the efficacy of immune checkpoint inhibitor in head and neck squamous cell carcinoma
Dong Hyun Kim, Seo Yoon Jang, Bhumsuk Keam
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2024) Vol. 138, Iss. 6, pp. 763-771
Closed Access | Times Cited: 2
Tea leaf-derived nanovesicles for ferric-supply-amplified ICD and macrophage reprogramming to boost immunotherapy against head and neck squamous carcinoma
Hanzhe Liu, Zhi Liu, Weilian Liang, et al.
Chemical Engineering Journal (2024) Vol. 503, pp. 158469-158469
Closed Access | Times Cited: 2
Antibiotics Significantly Decrease the Survival of Head and Neck Carcinoma Patients with Immunotherapy: A Real-World Analysis of More Than 3000 Cases
Saskia Preißner, Max Heiland, Robert Preißner, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2342-2342
Open Access | Times Cited: 5
Immunotherapy for HPV negative head and neck squamous cell carcinoma
Binyumeng Jiang, Ahmed Elkashif, Jonathan A. Coulter, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189138-189138
Open Access | Times Cited: 1
Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report
Ying Sun, Guanghui Yang, Ruijie Sun, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor
Takuya Tsuji, Ryo Asato, Shinpei Kada, et al.
Auris Nasus Larynx (2023) Vol. 51, Iss. 1, pp. 86-98
Closed Access | Times Cited: 3
Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma
Diana Odhiambo, Allison N. Pittman, Ashlyn G. Rickard, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 118, Iss. 5, pp. 1315-1327
Closed Access | Times Cited: 3
Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma
Jing Yang, Tao Song
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 3, pp. 909-919
Open Access
Tumour–associated inflammation in patients with advanced and relapsing hypopharyngeal carcinoma
Anna-Rebekka Staufenberg, Matthias M. Gaida, Claudine Graf, et al.
Laryngo-Rhino-Otologie (2024) Vol. 103
Closed Access
Page 1 - Next Page

Scroll to top